Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR76 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | C1orf162 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | ZEB1 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | ETS1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | BAG2 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | CFD | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | ACOT11 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | SPECC1L-ADORA2A | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
mRNA | KLF3 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |